Neurocrine Biosciences (NBIX) stock valuation

$162.10 Nov 18, 2026 · market cap $16.6B

11/121 investors
i

Neurocrine Biosciences trades at $162. Our three models put it at $53–$347 (base $153): between them. The models disagree widely, so read the base with care.

Cash Flow $347 · Buffett $153 · Damodaran $53 · models run Nov 18, 2026

11 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate NBIXCreate free account →

Full open-source research report for NBIX on DeepValues Research (CC BY 4.0)